Sign In
Buy TEVA
$32.83
-0.250 (-0.756%)
At Close: Jun 03, 2026
Teva Pharmaceuticals: Why It's Time To Cash Out (Rating Downgrade)
06:08pm, Tuesday, 23'rd Dec 2025
Teva, the Israeli pharmaceutical giant, is reaching new heights, breaking the $30 mark. The rise in its share price reflects both the strengthening of its balance sheet and the rising sales of Austedo
Teva Pharmaceutical Industries (NYSE:TEVA) Hits New 52-Week High Following Analyst Upgrade
01:16am, Tuesday, 23'rd Dec 2025
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA - Get Free Report)'s stock price hit a new 52-week high during trading on Monday after Piper Sandler raised their price target on the stock from $30.00
Teva Pharmaceutical Industries (NYSE:TEVA) CAO Sells $371,460.00 in Stock
05:03am, Sunday, 21'st Dec 2025
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA - Get Free Report) CAO Amir Weiss sold 12,300 shares of the business's stock in a transaction that occurred on Tuesday, December 16th. The stock was sol
Roberto Mignone Sells 77,400 Shares of Teva Pharmaceutical Industries (NYSE:TEVA) Stock
04:30am, Saturday, 20'th Dec 2025
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA - Get Free Report) Director Roberto Mignone sold 77,400 shares of the firm's stock in a transaction on Tuesday, December 16th. The shares were sold at a
Alvotech and Teva Secure U.S. Settlement Date for AVT06, a Proposed Biosimilar to Eylea®
03:40am, Friday, 19'th Dec 2025
REYKJAVIK, Iceland and TEL AVIV, Israel, Dec. 19, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for
My Top 10 Portfolio Holdings for 2026
03:06am, Friday, 19'th Dec 2025
It's been another banner year on Wall Street, with the Dow Jones Industrial Average, S&P 500, and Nasdaq Composite, respectively, higher by 14%, 16%, and 20% year-to-date. Although I've been a net sel
Here's Why Teva Pharmaceutical Industries Ltd. (TEVA) is a Strong Value Stock
10:41am, Thursday, 18'th Dec 2025
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
3 Things You Need to Know if You Buy Teva Pharmaceutical Stock Today
02:33pm, Wednesday, 17'th Dec 2025
Teva Pharmaceutical is one of the world's largest generic drug companies. Teva is working to differentiate itself in generics by focusing on harder-to-produce drugs.
Should You Forget Teva Pharmaceutical and Buy These Unstoppable Stocks Instead?
03:27pm, Sunday, 14'th Dec 2025
Shares of Teva -- a generic-drug maker with a history of losses and high leverage -- have rallied strongly. Pfizer and Merck, which make branded drugs, are financially strong and are rebuilding their
Teva Pharmaceutical Industries (NYSE:TEVA) VP Sells $3,311,622.24 in Stock
05:04am, Sunday, 14'th Dec 2025
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA - Get Free Report) VP Richard Daniell sold 115,468 shares of the business's stock in a transaction that occurred on Tuesday, December 9th. The stock was
Billionaire Stanley Druckenmiller is Betting $1.2 Billion in These 3 Stocks
09:11am, Thursday, 11'th Dec 2025
Stanley Druckenmiller is a Wall Street legend whose trades are truly worth tracking due to how consistently he has been winning.
TEVA Files NDA With FDA for Olanzapine LAI for Schizophrenia
10:46am, Wednesday, 10'th Dec 2025
Teva files an NDA seeking FDA approval for its once-monthly olanzapine LAI for the treatment of adults with schizophrenia.
Ardsley Advisory Partners LP Has $6.70 Million Holdings in Teva Pharmaceutical Industries Ltd. $TEVA
03:31am, Wednesday, 10'th Dec 2025
Ardsley Advisory Partners LP cut its position in shares of Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) by 20.0% in the second quarter, according to its most recent disclosure with the Securities
Teva Stock Trading Above 200- & 50-Day SMA for 2 Months: How to Play
12:16pm, Tuesday, 09'th Dec 2025
Teva holds bullish momentum, trading above key SMAs, as branded drugs and biosimilars drive growth despite generics softness.
Glenview Doubles Down on Teva Stock With $72 Million Buy, According to Recent SEC Filing
10:30am, Tuesday, 09'th Dec 2025
Glenview Capital Management added to its massive position in Teva Pharmaceuticals stock.
